Connect Biopharma is trading 6.13% up at $2.44, with the move appearing primarily sector-driven.
- Biotech ETF XBI is up 2.06% during regular trading, amid broader risk-on sentiment and gains across major U.S. indexes.
- No new company-specific announcement, earnings release, regulatory update, or analyst action was identified for August 25, 2026.
- Its latest major update, an August 12 second-quarter report, highlighted completed Phase 2 enrollment and September topline results; trading volume and activity data were unavailable.